# IMMUNOME INC (IMNM)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IMNM/

- Reporting holders: 4
- Reported value: $117.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $70.5K | 3,279 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $46.5K | 2,164 | 0.0% | 9 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $495 | 23 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $323 | 15 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $117.9K |
| Q2 2026 | 206 | $2.7B |
| Q1 2026 | 203 | $2.6B |
| Q4 2025 | 184 | $2.6B |
| Q3 2025 | 154 | $1.1B |
| Q2 2025 | 143 | $779.3M |
| Q1 2025 | 143 | $548.1M |
| Q4 2024 | 121 | $588.6M |
| Q3 2024 | 115 | $788.0M |
| Q2 2024 | 115 | $588.1M |
| Q1 2024 | 104 | $928.0M |
| Q4 2023 | 58 | $233.3M |